ELIZABETH HARPE: Open Payments
NPI 1881217776 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,217 in 53 payments from 15 companies in 2025. Trend: 2023 $1,180 · 2024 $1,422 · 2025 $1,217
Food & beverage: $1,217
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $378 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| Amgen Inc. | 5 | $101 |
| Merck Sharp & Dohme LLC | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| BridgeBio Pharma, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Novo Nordisk Inc | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Esperion Therapeutics, Inc. | 2 | $43 |
Products named: WAINUA, LOKELMA, Kerendia, REPATHA, JARDIANCE, Attruby, FARXIGA, VERQUVO.
Industry payments across NC — which companies pay providers there.
